Lexeo Therapeutics (LXEO) Common Equity (2022 - 2023)
Historic Common Equity for Lexeo Therapeutics (LXEO) over the last 2 years, with Q3 2023 value amounting to -$162.8 million.
- Lexeo Therapeutics' Common Equity fell 6448.91% to -$162.8 million in Q3 2023 from the same period last year, while for Sep 2023 it was -$162.8 million, marking a year-over-year decrease of 6448.91%. This contributed to the annual value of -$113.0 million for FY2022, which is N/A changed from last year.
- According to the latest figures from Q3 2023, Lexeo Therapeutics' Common Equity is -$162.8 million, which was down 6448.91% from -$113.0 million recorded in Q4 2022.
- Lexeo Therapeutics' Common Equity's 5-year high stood at -$99.0 million during Q3 2022, with a 5-year trough of -$162.8 million in Q3 2023.